- Home
- FORTY vs KNSA Comparison
FORTY vs KNSA Comparison
Compare FORTY & KNSA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FORTY
- KNSA
- Stock Information
- Founded
- FORTY 1985
- KNSA 2015
- Country
- FORTY Israel
- KNSA United Kingdom
- Employees
- FORTY N/A
- KNSA N/A
- Industry
- FORTY EDP Services
- KNSA Biotechnology: Pharmaceutical Preparations
- Sector
- FORTY Technology
- KNSA Health Care
- Exchange
- FORTY Nasdaq
- KNSA Nasdaq
- Market Cap
- FORTY 2.3B
- KNSA 2.6B
- IPO Year
- FORTY 1997
- KNSA 2018
- Fundamental
- Price
- FORTY $148.00
- KNSA $39.43
- Analyst Decision
- FORTY
- KNSA Strong Buy
- Analyst Count
- FORTY 0
- KNSA 7
- Target Price
- FORTY N/A
- KNSA $46.86
- AVG Volume (30 Days)
- FORTY 367.0
- KNSA 454.2K
- Earning Date
- FORTY 11-20-2025
- KNSA 10-28-2025
- Dividend Yield
- FORTY 0.96%
- KNSA N/A
- EPS Growth
- FORTY 15.06
- KNSA N/A
- EPS
- FORTY 4.97
- KNSA 0.47
- Revenue
- FORTY $2,889,481,000.00
- KNSA $597,973,000.00
- Revenue This Year
- FORTY N/A
- KNSA $53.93
- Revenue Next Year
- FORTY N/A
- KNSA $25.06
- P/E Ratio
- FORTY $28.18
- KNSA $84.46
- Revenue Growth
- FORTY 8.58
- KNSA 55.68
- 52 Week Low
- FORTY $77.50
- KNSA $17.82
- 52 Week High
- FORTY $151.31
- KNSA $42.05
- Technical
- Relative Strength Index (RSI)
- FORTY 64.71
- KNSA 59.56
- Support Level
- FORTY $142.00
- KNSA $38.02
- Resistance Level
- FORTY $151.31
- KNSA $39.45
- Average True Range (ATR)
- FORTY 0.95
- KNSA 1.50
- MACD
- FORTY 0.52
- KNSA -0.03
- Stochastic Oscillator
- FORTY 83.52
- KNSA 67.83
About FORTY Formula Systems (1985) Ltd.
Formula Systems (1985) Ltd is a holding company that, through its subsidiaries, provides information technology services. The company organizes itself into operating segments: The Matrix segment, which generates the majority of revenue, provides software development and existing software expansion services. The Sapiens segment provides software development services for the insurance industry. The Magic Software segment provides vendor management systems and workforce management services, which include accounting and finance, human resources, Michpal, ZAP Group, and Others. The majority of the company's revenue comes from Israel.
About KNSA Kiniksa Pharmaceuticals Ltd.
Kiniksa Pharmaceuticals International PLC is a clinical-stage biopharmaceutical company focused on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases. The company's clinical-stage product candidates include Rilonacept, abiprubart, and mavrilimumab.